This page does not provide dosing instructions. Any compound-specific plan depends on injury context, prior medical history, product source, route of administration, other medications, and clinician supervision. Expert Opinion
What can change clinician decision-making
- Whether the problem is tendon, ligament, muscle, nerve, or non-musculoskeletal pain
- Whether there is a history of malignancy, clotting issues, autoimmune disease, or uncontrolled inflammation
- Whether the product is verified and sourced from a regulated pharmacy rather than a gray-market vendor
- Whether the person is also using rehab, loading modification, imaging follow-up, or other therapies
Questions to ask a clinician
- What is the actual diagnosis, and what evidence supports it?
- What outcome would tell us this is helping versus just natural recovery?
- What safety monitoring would be required before and during use?
- What are the stop conditions if side effects or non-response show up?
- Are there more established options with stronger human evidence?
What people report
Online communities talk constantly about split dosing, loading phases, maintenance phases, and site-specific administration. Anecdotal That volume of discussion should not be confused with validated medical guidance.
Bottom line
Do not self-dose. If a plan cannot survive clinician review, source verification, and a conversation about side effects, it is not a protocol. It is improvisation with a sterile-looking vial.
Continue with administration routes, protocol concepts, and disclaimer.